Clopidogrel Bisulfate API USP

Clopidogrel Bisulfate is an antiplatelet agent used to prevent blood clots, stroke, and myocardial infarction, especially in patients with cardiovascular disease. It functions by selectively inhibiting ADP-induced platelet aggregation.

Salius Pharma supplies GMP-compliant Clopidogrel Bisulfate API with USP and EP specifications, ideal for formulation into oral tablets. We offer regulatory support including DMF (Drug Master File) and COA for streamlined registration and market entry.

Applications:
Used in the manufacture of oral antiplatelet medications for stroke prevention, post-PCI care, and dual antiplatelet therapy.